In preclinical studies using rodent models, tri agonist peptides similar to Retatrutide have been associated with coordinated changes in biomarkers linked to energy metabolism, lipid handling, and endocrine signaling[5]
Emerging options like retatrutide and survodutide are also entering the research landscape
Its side effects can include digestive issues
Incretins: their physiology and application in the treatment of diabetes mellitus
Speaking on "The Howard Stern Show" in January 2025, Schumer, who's said a lot about her weight loss journey, said she took Ozempic around 2022 but had to stop because it resulted in severe nausea
Though these drugs have been prescribed for people with diabetes for decades, the conversation around their use for weight loss has exploded in the past couple of years